We have also included and presently extracting 28 new pharmacological and/or preventive RCTs:
| Borges M, Revista Universidad, Ciencia y Tecnologia, 2021 |
EXPERIMENTAL STUDY: MANAGEMENT OF METISOPRINOL IN PATIENTS WITH COVID-19 |
| Bundgaard H, Ann Intern Med. 2020 |
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers |
| Cadegiani F, Cureus, 2021 |
Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Bioch |
| Cadegiani F, medRxiv, 2020 |
5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men. |
| Cadegiani F, ResearchSquare, 2021 |
Proxalutamide (GT0918) Reduces the Rate of Hospitalization and Death in COVID-19 Male Patients: A Randomized Double-Blinded Placebo-Controlled Trial. |
| Cadegiani FA, Research Square, 2020 |
Dutasteride Reduces Viral Shedding, Inflammatory Responses and Time-to-Remission in COVID-19: Biochemical Findings of a Randomized Double-Blind Placebo Controlled Interventional Trial (DUTA AndroCoV-Trial - Biochemical). |
| Dabbous H, Arch Virol, 2021 |
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study |
| Darazam I, ResearchSquare, 2021 |
Role of Interferon Therapy in Severe COVID-19: The COVIFERON Randomized Controlled Trial |
| Darazam I, ResearchSquare, 2021 |
An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19 |
| Fontanesi Blum, SSRN, 2021 |
Nitazoxanide In Vitro Efficacy Against SARS CoV-2 and In Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind Clinical Trial |
| Ghahremani M, ResearchSquare, 2021 |
Exogenous Surfactant Versus Placebo in the Treatment of Moderate and Severe ARDS in COVID-19: The Pilot Study of a Clinical Trial |
| HERNANDEZ-CARDENAS C, medRxiv, 2021 |
HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIAL |
| Holubovska O, medRxiv, 2021 |
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial |
| Johnston C, SSRN, 2021 |
Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial |
| Lopardo G, SSRN, 2021 |
RBD-Specific Polyclonal F(ab´) |
| Ramakrishnan S, medRxiv, 2021 |
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial |
| Ranjbar K, ResearchSquare, 2021 |
Methylprednisolone or Dexamethasone, Which One Is the Superior Corticosteroid in the Treatment of Hospitalized COVID-19 Patients: A Triple-Blinded Randomized Controlled Trial |
| Rashad A, ResearchSquare, 2021 |
Therapeutic efficacy of macrolides in management of patients with mild COVID-19 |
| Sali S, Novelty in Biomedicine, 2021 |
Comparison of the Efficacy of Sofosbuvir and Kaletra on Outcome of Covid-19. Is Sofosbuvir A Potential Treatment For COVID-19? |
| Shah Bukhari K H, medRxiv, 2021 |
Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate Disease |
| Shouman W, J Clin Diagn Res, 2021 |
Use of Ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt : A Randomised clinical trial |
| Tang X, Respiration, 2021 |
Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial. |
| Thakar A, Indian J Med Res, 2021 |
Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial. |
| Thomas S, JAMA Netw Open, 2021 |
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. |
| Tornling G, medRxiv, 2021 |
The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial |
| Torres-Zambrano GM, medRxiv, 2020 |
Renal Involvement in patients with COVID-19 Pneumonia and Outcomes after Stem Cell Nebulization |
| Wu X, Neuropsychiatry, 2020 |
Application of Psychological Support Therapy in the Treatment of Patients with COVID-19 Complicated With Emotional Disorders: A Randomized Controlled Trial |
| Khalili H, Acta Biomed, 2020 |
Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19 |
In addition to 10 RCT evaluating Non-pharmacological interventions and long COVID treatments included and pending extraction: